November 19, 2019
Genomeweb
Exact Sciences, focused on the early detection and prevention of colorectal cancer.
Exact Sciences is a Public company. E... Read more
Exact Sciences's Competitors, Revenue, Number of Employees, Funding and Acquisitions
Followers on Owler
164
Followers on Owler
Based on data from Exact Sciences's latest SEC filings
Annual Revenue
Based on data from Exact Sciences's latest SEC filings
Employees
Chairman & CEO
Kevin T. Conroy
OVERVIEW
Founded:
1995
Headquarters:
MadisonWisconsin
Status:
PublicIndependent Company of NASDAQEXAS
Industry Sector:
Health Care Services
SIC Code:
8000NAICS listing »
Top Competitors or Alternatives
Missing a competitor? Contribute!
Weigh-in!
Help the Owler community know moreTrending News for Exact Sciences and Exact Sciences's Competitors
Today 3:29 AM
Benzinga
ROSEN, A GLOBALLY RANKED LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important Deadline in Securities Class Action - MYGN
NEW YORK, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, remind... See more »
November 18, 2019
Business Insider
A genetic testing firm launched an atrial fibrillation research app on Apple devices
This story was delivered to Business Insider Intelligence Digital Health Pro subscribers earlier this... See more »
Competitive Analysis
TOP COMPETITORS OR ALTERNATIVES
Polymedco is the top competitor of Exact Sciences. Polymedco is headquartered in Cortlandt Manor, New York, and was founded in 1980. Polymedco competes in the Health Care Equipment field. Polymedco generates 4.64% the revenue of Exact Sciences.
Genomic Expression is perceived as one of Exact Sciences's biggest rivals. Genomic Expression was founded in New York, New York} in 2009. Like Exact Sciences, Genomic Expression also operates in the Health Care Services industry. Compared to Exact Sciences, Genomic Expression generates $716.1M less revenue.
RANK
COMPANY
LEADERSHIP
EMPLOYEES
TOTAL FUNDING
REVENUE
Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$723.7M
Exact Sciences's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 535.2M. Over the last four quarters, Exact Sciences's revenue has grown by 53%. Specifically, in Q3 2019's revenue was $218.8M; in Q2 2019, it was $199.9M; in Q1 2019, it was $162M; in Q4 2018, Exact Sciences's revenue was $143M.
Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Genomic Health Inc
Jul 2019
Source »$2.8B
Genomic Health is a biotechnology company that provides genomic-based diagnostic test services to the treatment of early-stage cancer.
Biomatrica, Inc.
Oct 2018
Source »undisclosed
Biomatrica is a biotechnology company that develops chemicals for ambient temperature preservation of biological materials.
These are all the companies that Exact Sciences has acquired. Exact Sciences has acquired 2 companies and its latest acquisition was Genomic Health Inc in Jul 2019. Genomic Health is a biotechnology company that provides genomic-based diagnostic test services to the treatment of early-stage cancer.
Exact Sciences Funding History
Since Exact Sciences was founded in 1995, it has participated in 2 rounds of funding. In total Exact Sciences has raised $64.2M. Exact Sciences' last funding round was on Jan 2001 for a total of $56.0M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
IPO
Jan 2001
$56M
Equity
Jun 2009
$8.2M
-
Total Funding: $64.2M
Since Exact Sciences was founded in 1995, it has participated in 2 rounds of funding. In total Exact Sciences has raised $64.2M. Exact Sciences' last funding round was on Jan 2001 for a total of $56.0M
Investments
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
These are all the companies that Exact Sciences has invested in. Exact Sciences has invested 2 companies and its latest investment was Genomic Health Inc in Jul 2019. Genomic Health is a biotechnology company that provides genomic-based diagnostic test services to the treatment of early-stage cancer.
Exact Sciences News
November 13, 2019beckersasc
Exact Sciences closed its $2.8 billion acquisition of Genomic Health
Exact Sciences closed its $2.8 billion acquisition of Genomic Health Nov. 8, securing rights to Genom... See more »
November 12, 2019FierceBiotech
Exact Sciences nets FDA breakthrough designation for liver cancer blood test
Exact Sciences announced it received a breakthrough device designation from the FDA for its blood-bas... See more »
November 8, 2019The Business Journals: Greensboro/Winston-Salem/High Point
Exact Sciences completes $2.8B acquisition of Genomic Health
Exact Sciences Corp., the Madison-based maker of the Cologuard take-home colon cancer test and one of... See more »
November 8, 2019Seeking Alpha
Exact Sciences liver cancer test nabs accelerated review status in U.S.
November 8, 2019DirectorsTalk Interviews
Exact Sciences Corporation - Consenus Indicates Potential 56.5% Upside
Exact Sciences Corporation with ticker code (EXAS) have now 11 analysts covering the stock. The analy... See more »
November 1, 2019BioSpace
Exact Sciences to participate in November 2019 investor conferences
Exact Sciences Corp. announced that company management will be presenting at the following investor c... See more »
October 30, 2019The Business Journals: Greensboro/Winston-Salem/High Point
Genomic Health's longtime leader Popovits leaving after $3B purchase by Exact Sciences
Longtime Genomic Health Inc. top executive Kim Popovits will leave the company as the company's buyer... See more »
Exact Sciences Blogs
May 15, 2015EXACT SCIENCES BLOG
Exact Sciences' Stool DNA Screening Technology Featured in Posters at Digestive Disease Week 2015
December 9, 2014EXACT SCIENCES BLOG
Exact Sciences Named A Best Company To Work For By In Business Madison
Exact Sciences Press Releases
March 1, 2019centralcharts
Exact Sciences to participate in March investor conferences
Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention... See more »
December 20, 2018centralcharts
Exact Sciences to participate in J.P. Morgan Healthcare Conference
Exact Sciences to participate in J.P. Morgan Healthcare Conference
PR Newswire
MADISON, Wis., Dec. 2... See more »
November 9, 2018PR Newswire
Exact Sciences to participate in two November investor conferences
MADISON, Wis., Nov. 9, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that ... See more »
October 30, 2018PR Newswire
Cologuard® revenue increased 63 percent to $118 million, and Cologuard test volume grew 49 percent to 241,000 during third quarter
MADISON, Wis., Oct. 30, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that... See more »
August 1, 2018PR Newswire
Cologuard® revenue increased 78 percent to $103 million during second quarter
MADISON, Wis., Aug. 1, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that ... See more »
August 1, 2018PR Newswire
Exact Sciences Selects Vodori's Pepper Flow to Support Commercialization of Cologuard
CHICAGO, Aug. 1, 2018 /PRNewswire/ -- Vodori, Inc., an innovator in life science content management, ... See more »
Exact Sciences Videos
August 27, 2018Exact Sciences Youtube Channel
"Fight Colorectal Cancer Ambassador John MacLeod: I'm still here." on YOUTUBE
Social Statistics
Headquarters
Trending Companies
IN THE NEWS
RedDoorz | OnePlus | Industrial Distribution | Dunkin' Donuts | Ionis Pharmaceuticals | Williams | Fujitsu | World Fuel Services | 2U | Ethiopian | eBay | NVIDIA | KAR Auction Services | Vivo | Rockwell Automation | Amedisys | St. Patrick St. Vincent High School | Johnson & Johnson | Airbus | Tata | Boston Scientific | WhatsApp | Citrix | Edison | OPay | Arrcus | Genentech | Jadestone Energy | Nissan | Azelio | Novartis | Cell C | Dover | Biman Bangladesh Airlines | NRG | Sunkist | Rblaw | GroupM | Etihad | Reliance Communications | Mystifly | Wight & Company | Elavon | Tesla | Relic Entertainment | CyberArk Software | Norwest Venture Partners | PulteGroup | W/E | Bio-Rad
PEOPLE ALSO VIEWED
CyberScholar | Worldstrides | Dksh | GlobalFit | Functional Blends Organic Skin Care | SMIC | GoodnewsIndia | Karmak | Marcum | P-Cure | Mission Restaurant Supply | Info Grains | Gradifi | VizExplorer | SIS Group | DSU | MacroPoint | Pepperidge Farm | SenhaSegura | American Fidelity | Tauchpartner Lapalma | Shropshire Council - County Training | Samsa | Clevelandwebdesignquotes | Tim Sipprell At Keller Williams Realty Integrity Lakes | G3Group | Acerepairs | CANEVARI PLASTICS | Fair Flies | Allied Public Adjusters
Summary
ABOUT
Overview
Exact Sciences, focused on the early detection and prevention of colorectal cancer. Exact Sciences was founded in 1995. Exact Sciences' headquarters is located in Madison, Wisconsin, USA 53719. It has raised 64.2M in 2 rounds. The latest round was in ...
CEO
Exact Sciences's Chairman & CEO, Kevin T. Conroy, currently has an approval rating of 90%. Exact Sciences's primary competitors are Polymedco, Genomic Expression & Hemosure.Website
exactsciences.comFrequently Asked Questions about Exact Sciences
When was Exact Sciences founded?
Exact Sciences was founded in 1995Who is Exact Sciences's CEO?
Exact Sciences's CEO is Kevin T. ConroyHow much revenue does Exact Sciences generate?
Exact Sciences generates $723.7M in revenueHow much funding does Exact Sciences have?
Exact Sciences has historically raised $64.2M in fundingWhere is Exact Sciences's headquarters?
Exact Sciences's headquarters is in Madison Wisconsin, USA
How many employees does Exact Sciences have?
Exact Sciences has 1,977 employeesWhat sector does Exact Sciences operate in?
Exact Sciences is in Health Care ServicesWho are Exact Sciences's competitors?
Exact Sciences's top competitors are Polymedco, Genomic Expression, HemosureWho has Exact Sciences invested in?
Exact Sciences's has invested in companies such as Thrive Earlier Detection
